637 HIV+ children write to Centre asking it to pay Cipla for live-saving drug: The Hindu

Source: Scroll, March 6, 2017

The pharma company has stopped production of the Lopainavir syrup saying it has not recovered its dues from the government.

637 HIV+ children write to Centre asking it to pay Cipla for live-saving drug: The Hindu

As many as 637 children living with HIV have written to Prime Minister Narendra urging him to look into an alleged delay in payments to pharmaceutical company Cipla, which has led to the firm discontinuing a life-saving drug. The company has stopped producing the Lopinavir syrup citing “delay in payments by the national programme for the HIV medicines by several years and even non-payment of its dues in many cases”, reported The Hindu.

The March 4 letter addressed to the PM, the finance minister and the health minister requests the administration to “look into the matter of HIV drug stock out, in general, and in particular paediatric HIV medicines to ensure that they are not merely exported but also actually available to the children in this country”. Cipla had stopped participating in government tenders after non-payment for its consignments by the Health Ministry in 2014.

The ministry has asked State AIDS Control Societies to buy the drug from local markets. “An emergency tender has been placed but we have instructed SACS and State Governments to purchase from local markets,” Arun Panda, Additional Secretary, Health Ministry, told The Hindu. However, Cipla was the only company producing the drug, so it has gone out of stock in local markets as well.

Advertisements
This entry was posted in HIV/Aids, Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s